Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...
The GLP-1 food market is booming, with global value hitting $53bn and major brands like Nestlé and General Mills launching ...
Across the US, roughly 1 in 10 adults struggle with alcohol use disorder — a medical condition that makes quitting feel ...
People with excess body fat who also had stronger handgrip strength were less likely to develop obesity-related heart, liver ...
Discover how FTIR spectroscopy enhances quality control in GLP-1 weight loss drug production by ensuring molecular ...
Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...
Health and Me on MSN
Ozempic Sober - Is The Popular Weight Loss Drug Making People Lose Interest In Alcohol?
Weight loss drugs are being researched more as it becomes more popular. While there are many unusual side-effects linked to ...
A raft of favorable Supreme Court emergency decisions this year — stripping protections for hundreds of thousands of immigrants with temporary protections, among them — has given Trump space to ...
GLP-1 drugs such as Ozempic are accelerating interest in protein to address the loss of lean muscle mass that can accompany ...
Novo Nordisk's Alzheimer's trial really is like a lottery ticket. If it wins, the company gains a transformational new market ...
New research shows that substantially more Americans would qualify as being obese using new diagnostic criteria released this ...
The study further found that 21% of children and young people on the waiting list are waiting for speech and language therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback